CINCINNATI, November 6, 2014 - Omnicare, Inc. (NYSE: OCR) (the "Company") announced today that it has priced its public offering of $400 million aggregate principal amount of 4.75% Senior Notes due 2022 (the "2022 Notes") at 100% of principal amount, and $300 million aggregate principal amount of 5.00% Senior Notes due 2024 (the "2024 Notes" and, together with the 2022 Notes, the "Notes") at 100% of principal amount. The sale of the Notes is expected to close on November 21, 2014, subject to customary closing conditions.
The Company expects to use the net proceeds from the Notes offering to fund the redemption of all $400 million aggregate principal amount outstanding of its 7.75% Senior Subordinated Notes due 2020 and for general corporate purposes, including refinancing a portion of its other outstanding debt securities.
The Notes are being offered pursuant to the Company's shelf registration statement, which became automatically effective upon filing with the Securities and Exchange Commission. A prospectus supplement and accompanying prospectus describing the terms of the offering will be filed with the Securities and Exchange Commission. BofA Merrill Lynch, Barclays, Goldman, Sachs & Co., J.P. Morgan, and SunTrust Robinson Humphrey are acting as joint book-running managers for the Notes offering. Copies of the prospectus supplement and the accompanying prospectus for the Notes offering may be obtained from BofA Merrill Lynch, 222 Broadway, New York, New York 10038, Attention: Prospectus Department, or by emailing: dg.prospectus_requests@baml.com (mailto:dg.prospectus_requests@baml.com); Barclays, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by emailing: Barclaysprospectus@broadridge.com (mailto:Barclaysprospectus@broadridge.com); Goldman, Sachs & Co., 200 West Street, New York, New York 10282, or by emailing: prospectus-ny@ny.email.gs.com (mailto:prospectus-ny@ny.email.gs.com); J.P. Morgan, 383 Madison Avenue, 3rd Floor, New York, New York 10179; or SunTrust Robinson Humphrey, Attn: Prospectus Department, 3333 Peachtree Road NE, Atlanta, Georgia 30326.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
About Omnicare
Omnicare, Inc., a Fortune 500 company based in Cincinnati, Ohio, provides comprehensive pharmaceutical services to patients and providers across the United States. As the market-leader in professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other chronic care institutions, Omnicare leverages its unparalleled clinical insight into the geriatric market along with some of the industry's most innovative technological capabilities to the benefit of its long-term care customers. Omnicare also provides specialty pharmacy and key commercialization services for the bio-pharmaceutical industry through its Specialty Care Group.
Forward-looking Statements
In addition to historical information, this report contains certain statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, all statements regarding the intent, belief or current expectations regarding the matters discussed or incorporated by reference in this document (including statements as to "beliefs," "expectations," "anticipations," "intentions" or similar words) and all statements which are not statements of historical fact. Such forward-looking statements, together with other statements that are not historical, are based on management's current expectations and involve known and unknown risks, uncertainties, contingencies and other factors that could cause results, performance or achievements to differ materially from those stated. The most significant of such risks and uncertainties are described in the Company's Form 10-K, Form 10-Q and Form 8-K reports filed with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, the Company's actual results, performance or achievements could differ materially from those expressed in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.
# # #
Contact:
Patrick C. Lee
(513) 719-1507
patrick.lee@omnicare.com
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Omnicare via Globenewswire
